Matrix metalloproteinase-2 and -9 activities in the human lens epithelial cells and serum of steroid induced posterior subcapsular cataracts

Molecular Vision

Volumn 18, Issue , 2012, Pages 64-73

  Alapure, Bhagwat V ^a   Praveen, Mamidipudi R ^a   Gajjar, Devarshi U ^a   Vasavada, Abhay R ^a   Parmar, Trilok J ^a   Arora, Anshul I ^a  

^a ILADEVI CATARACT AND IOL RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DEXAMETHASONE; DOXOFYLLINE; GELATINASE A; GELATINASE B; MESSENGER RNA; PREDNISOLONE; PREDNISOLONE ACETATE; STEROID;

ADULT; AGED; ALLERGY; ANTERIOR LENS CAPSULE; ARTHRITIS; ARTICLE; ASTHMA; CATARACT; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOLOCALIZATION; LENS EPITHELIUM; LUNG DISEASE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OBSERVATIONAL STUDY; POSTERIOR SUBCAPSULAR CATARACT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; QUANTITATIVE REAL TIME POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; RENAL GRAFT DYSFUNCTION; SCHOOL CHILD; STEROID INDUCED POSTERIOR SUBCAPSULAR CATARACT; SUBCAPSULAR CATARACT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CAPSULE OPACIFICATION; CHILD; CYCLOSPORINE; DEXAMETHASONE; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POSTERIOR CAPSULE OF THE LENS; PREDNISOLONE; PROSPECTIVE STUDIES; RNA, MESSENGER;

EID: 84856806674     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Nagata M, Matsuura H, Fujinaga Y. Ultrastructure of posterior subcapsular cataract in human lens. Ophthalmic Res 1986; 18:180-4. [PMID: 3748551]
2. Black RL, Oglesby RB, Von Sallmann L, Bunim JJ. Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis. JAMA 1960; 174:166-71. [PMID: 13801171]
3. Giles CL, Mason GL, Duff IF, McLean JA. The association of cataract formation and systemic corticosteroid therapy. JAMA 1962; 182:719-22. [PMID: 13947854]
4. Jobling AI, Augusteyn RC. What causes steroid cataracts? A review of steroid-induced posterior subcapsular cataracts. Clin Exp Optom 2002; 85:61-75. [PMID: 11952401]
5. Tripathi RC, Tripathi BJ. The eye. In: Riddell R, editor. Pathology of drug-induced and toxic diseases. New York (NY): Churchill Livingstone; 1982. p. 377-456.
6. James ER. The etiology of steroid cataract. J Ocul Pharmacol Ther 2007; 23:403-20. [PMID: 17900234]
7. Gabison EE, Hoang-Xuan T, Mauviel A, Menashi S. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie 2005; 87:361-8. [PMID: 15781323]
8. Szabo K, Ablin R, Singh G. Matrix metalloproteinases and the immune response. Clin Appl Immunol Rev 2004; 4:295-319.
9. Nathu Z, Dwivedi DJ, Reddan JR, Sheardown H, Margetts PJ, West-Mays JA. Temporal changes in MMP mRNA expression in the lens epithelium during anterior subcapsular cataract formation. Exp Eye Res 2009; 88:323-30. [PMID: 18809398]
10. Awasthi N, Wang-Su ST, Wagner BJ. Downregulation of MMP-2 and -9 by proteasome inhibition: a possible mechanism to decrease LEC migration and prevent posterior capsular opacification. Invest Ophthalmol Vis Sci 2008; 49:1998-2003. [PMID: 18436832]
11. Wormstone IM, Tamiya S, Anderson I, Duncan G. TGF-beta2-induced matrix modification and cell transdifferentiation in the human lens capsular bag. Invest Ophthalmol Vis Sci 2002; 43:2301-8. [PMID: 12091431]
12. Dwivedi DJ, Pino G, Banh A, Nathu Z, Howchin D, Margetts P, Sivak JG, West-Mays JA. Matrix metalloproteinase inhibitors suppress transforming growth factor-beta-induced subcapsular cataract formation. Am J Pathol 2006; 168:69-79. [PMID: 16400010]
13. Jiang Q, Zhou C, Bi Z, Wan Y. EGF-induced cell migration is mediated by ERK and PI3K/AKT pathways in cultured human lens epithelial cells. J Ocul Pharmacol Ther 2006; 22:93-102. [PMID: 16722795]
14. Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 2002; 21:1-14. [PMID: 11906808]
15. Wong TT, Daniels JT, Crowston JG, Khaw PT. MMP inhibition prevents human lens epithelial cell migration and contraction of the lens capsule. Br J Ophthalmol 2004; 88:868-72. [PMID: 15205227]
16. West-Mays JA, Pino G. Matrix Metalloproteinases as Mediators of Primary and Secondary Cataracts. Expert Rev Ophthalmol 2007; 2:931-8. [PMID: 19018298]
17. Di Girolamo N, Lloyd A, McCluskey P, Filipic M, Wakefield D. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol 1997; 150:653-66. [PMID: 9033278].
18. Di Girolamo N, Wakefield D, Coroneo MT. Differential expression of matrix metalloproteinases and their tissue inhibitors at the advancing pterygium head. Invest Ophthalmol Vis Sci 2000; 41:4142-9. [PMID: 11095607]
19. Sachdev NH, Di Girolamo N, Nolan TM, McCluskey PJ, Wakefield D, Coroneo MT. Differential expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the human lens: implications for cortical cataract formation. Invest Ophthalmol Vis Sci 2004; 45:4075-82. [PMID: 15505058]
20. Alapure BV, Praveen MR, Gajjar D, Vasavada AR, Rajkumar S, Johar K. Matrix metalloproteinase-9 activity in human lens epithelial cells of cortical, posterior subcapsular, and nuclear cataracts. J Cataract Refract Surg 2008; 34:2063-7. [PMID: 19027560]
21. Vasavada AR, Desai JP. Stop, chop, chop, and stuff. J Cataract Refract Surg 1996; 22:526-9. [PMID: 8784620]
22. Emery JM. Kelman phacoemulsification; patient selection. In: Emery JM, McIntyre DJ, editors. Extracapsular Cataract Surgery. St. Louis, MO: CV Mosby; 1983. p. 95-100.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. J Biol Chem 1951; 193:265-75. [PMID: 14907713]
24. Rao SK, Mathrubutham M, Karteron A, Sorensen K, Cohen JR. A versatile microassay for elastase using succinylated elastin. Anal Biochem 1997; 250:222-7. [PMID: 9245442]
25. Baragi VM, Shaw BJ, Renkiewicz RR, Kuipers PJ, Welgus HG, Mathrubutham M, Cohen JR, Rao SK. A versatile assay for gelatinases using succinylated gelatin. Matrix Biol 2000; 19:267-73. [PMID: 10936451]
26. el-Shabrawi Y, Eckhardt M, Berghold A, Faulborn J, Auboeck L, Mangge H, Ardjomand N. Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone. Eye (Lond) 2000; 14:375-83. [PMID: 11027004]
27. Tamiya S, Wormstone IM, Marcantonio JM, Gavrilovic J, Duncan G. Induction of matrix metalloproteinases 2 and 9 following stress to the lens. Exp Eye Res 2000; 71:591-7. [PMID: 11095911]
28. Seomun Y, Kim J, Lee EH, Joo CK. Overexpression of matrix metalloproteinase-2 mediates phenotypic transformation of lens epithelial cells. Biochem J 2001; 358:41-8. [PMID: 11485550]
29. Diekmann U, Zarbock R, Hendig D, Szliska C, Kleesiek K, Götting C. Elevated circulating levels of matrix metalloproteinases MMP-2 and MMP-9 in pseudoxanthoma elasticum patients. J Mol Med 2009; 87:965-70. [PMID: 19575173]
30. Awasthi N, Wagner BJ. Suppression of human lens epithelial cell proliferation by proteasome inhibition, a potential defense against posterior capsular opacification. Invest Ophthalmol Vis Sci 2006; 47:4482-9. [PMID: 17003443]
31. Galli A, Svegliati-Baroni G, Ceni E, Milani S, Ridolfi F, Salzano R, Tarocchi M, Grappone C, Pellegrini G, Benedetti A, Surrenti C, Casini A. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP-2-mediated mechanism. Hepatology 2005; 41:1074-84. [PMID: 15841469]
32. Lu Y, Wahl LM. Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/Akt/IKKalpha/NF-kappaB pathway. J Leukoc Biol 2005; 78:259-65. [PMID: 15800029]
33. Valentin F, Bueb JL, Kieffer P, Tschirhart E, Atkinson J. Oxidative stress activates MMP-2 in cultured human coronary smooth muscle cells. Fundam Clin Pharmacol 2005; 19:661-7. [PMID: 16313278]
34. Ye HQ, Azar DT. Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing. Invest Ophthalmol Vis Sci 1998; 39:913-21. [PMID: 9579471]
35. Wu CY, Wu MS, Chiang EP, Chen YJ, Chen CJ, Chi NH, Shih YT, Chen GH, Lin JT. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution. Clin Cancer Res 2007; 13:2054-60. [PMID: 17404086]
36. St-Pierre Y, Desrosiers M, Tremblay P, Estève PO, Opdenakker G. Flow cytometric analysis of gelatinase B (MMP-9) activity using immobilized fluorescent substrate on microspheres. Cytometry 1996; 25:374-80. [PMID: 8946145]
37. Choe KH, Taraseviciene-Stewart L, Scerbavicius R, Gera L, Tuder RM, Voelkel NF. Methylprednisolone causes matrix metalloproteinase-dependent emphysema in adult rats. Am J Respir Crit Care Med 2003; 167:1516-21. [PMID: 12522028]
38. Bianchi R, Rodella L, Rezzani R. Cyclosporine A up-regulates expression of matrix metalloproteinase 2 and vascular endothelial growth factor in rat heart. Int Immunopharmacol 2003; 3:427-33. [PMID: 12639820]
39. Zhou WH, Du MR, Dong L, Zhu XY, Yang JY, He YY, Li DJ. Cyclosporin A increases expression of matrix metalloproteinase 9 and 2 and invasiveness in vitro of the first-trimester human trophoblast cells via the mitogenactivated protein kinase pathway. Hum Reprod 2007; 22:2743-50. [PMID: 17566014]
40. Poulalhon N, Farge D, Roos N, Tacheau C, Neuzillet C, Michel L, Mauviel A, Verrecchia F. Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin. A direct role as an antifibrotic agent? J Biol Chem 2006; 281:33045-52. [PMID: 16914544]
41. Farias E, Ranuncolo S, Cresta C, Specterman S, Armanasco E, Varela M, Lastiri J, Pallotta MG, Balde Kier Joffe E, Puricelli L. Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients. Int J Cancer 2000; 89:389-94. [PMID: 10956415]
42. Chung TW, Kim JR, Suh JI, Lee YC, Chang YC, Chung TH, Kim CH. Correlation between plasma levels of matrix metalloproteinase (MMP)-9 /MMP-2 ratio and alphafetoproteins in chronic hepatitis carrying hepatitis B virus. J Gastroenterol Hepatol 2004; 19:565-71. [PMID: 15086601]
43. Ohbayashi H. Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci 2002; 3:409-21. [PMID: 12370004]
44. Tchetverikov I, Ronday HK, Van El B, Kiers GH, Verzijl N, TeKoppele JM, Huizinga TW, DeGroot J, Hanemaaijer R. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis. Ann Rheum Dis 2004; 63:881-3. [PMID: 15194590]
45. Lorenzl S, Albers DS, Relkin N, Ngyuen T, Hilgenberg SL, Chirichigno J, Cudkowicz ME, Beal MF. Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochem Int 2003; 43:191-6. [PMID: 12689599]
46. Grandas OH, Mountain DH, Kirkpatrick SS, Cassada DC, Stevens SL, Freeman MB, Goldman MH. Regulation of vascular smooth muscle cell expression and function of matrix metalloproteinases is mediated by estrogen and progesterone exposure. J Vasc Surg 2009; 49:185-91. [PMID: 18829229]
47. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002; 90:251-62. [PMID: 11861412]
48. Ries C, Egea V, Karow M, Kolb H, Jochum M, Neth P. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 2007; 109:4055-63. [PMID: 17197427]
49. Girolamo F, Virgintino D, Errede M, Capobianco C, Bernardini N, Bertossi M, Roncali L. Involvement of metalloprotease-2 in the development of human brain microvessels. Histochem Cell Biol 2004; 122:261-70. [PMID: 15375663]